A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04547127 · COMPLETED
Trial details
- NCT number
- NCT04547127
- Sponsor
- Instituto Grifols, S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-29
- Primary completion
- 2021-02-04
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.